Back
ACRES Commercial Realty Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
75
ACR
ACRES Commercial Realty
Last Price:
16.60
Seasonality Move:
1.41%
Sell
20
ALNY
Alnylam Pharmaceuticals
Last Price:
235.53
Seasonality Move:
10.85%
Buy
75
ACRES Commercial Realty (ACR)
is a Buy
Is ACRES Commercial Realty a Buy, Sell or Hold?
- The current ACRES Commercial Realty [ACR] share price is $16.74. The Score for ACR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ACR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $235.56. The Score for ALNY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ACR Stock Price Chart
What is ACRES Commercial Realty's stock price today?
-
The ACRES Commercial Realty share price today is $16.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $235.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ACR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 69.24 | Buy |
| Chaikin Money Flow: | 28985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.2 - 16.1) | Buy |
| Bollinger Bands (100): | (14.16 - 16.02) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.97 | Sell |
| Relative Strength Index (14 RSI): | 27.06 | Sell |
| Chaikin Money Flow: | -1631558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (264.56 - 293.18) | Sell |
| Bollinger Bands (100): | (249.23 - 281.59) | Sell |
ACR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.22 | Buy |
| 20-day SMA: | 15.68 | Buy |
| 50-day SMA: | 15.61 | Buy |
| 200-day SMA: | 13.75 | Buy |
| 8-day EMA: | 16.19 | Buy |
| 20-day EMA: | 15.88 | Buy |
| 50-day EMA: | 15.58 | Buy |
| 200-day EMA: | 13.8 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 266.17 | Sell |
| 20-day SMA: | 276.01 | Sell |
| 50-day SMA: | 273.94 | Sell |
| 200-day SMA: | 209.89 | Buy |
| 8-day EMA: | 261.6 | Sell |
| 20-day EMA: | 270.55 | Sell |
| 50-day EMA: | 270.52 | Sell |
| 200-day EMA: | 230.49 | Buy |
ACRES Commercial Realty Earnings Growth & ACR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.38 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
ACRES Commercial Realty Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||